HCPLive Network


Allopurinol initiation is associated with a modestly reduced risk of death in patients with hyperuricemia and gout, according to a study published online March 24 in the Annals of the Rheumatic Diseases.
Trial results showed the anti-gout medication colchicine reduced the rate of pericarditis recurrence and hospitalization compared to placebo.
Adding uric acid to standard thrombolytic therapy may reduce the risk of disability among stroke patients.
Theodore Fields, MD, explains the new mechanisms available in gout treatment and management, and a new study presented at the annual meeting of the American College of Rheumatologists.
Patients need to be taught better about what it means to have gout and understand that it is an ongoing disease, according to Theodore Fields, MD. Even if the patient’s acute attack is treated, they can gradually get worse if the uric acid isn't brought down.
Since gout isn’t something that is taught in medical school there’s a gap in knowledge among primary care physicians about the treatment of gout that needs to be addressed.
Gout Upcoming Events
Pentagon City, VA
April 6, 2014
August 7-9, 2014
Louisville, KY
San Diego, CA
September 17-20, 2014
Houston, TX
September 12-15, 2014
Boston, MA
November 14-19, 2014
Las Vegas, NV
May 14-17, 2015
Gout Resources